Positron Emission Tomography Imaging of Neurotensin Receptor-Positive Tumors with 68Ga-Labeled Antagonists: The Chelate Makes the Difference Again.

Journal of Medicinal Chemistry
Emma RenardVictor Goncalves

Abstract

Neurotensin receptor 1 (NTS1) is involved in the development and progression of numerous cancers, which makes it an interesting target for the development of diagnostic and therapeutic agents. A small molecule NTS1 antagonist, named [177Lu]Lu-IPN01087, is currently evaluated in phase I/II clinical trials for the targeted therapy of neurotensin receptor-positive cancers. In this study, we synthesized seven compounds based on the structure of NTS1 antagonists, bearing different chelating agents, and radiolabeled them with gallium-68 for PET imaging. These compounds were evaluated in vitro and in vivo in mice bearing a HT-29 xenograft. The compound [68Ga]Ga-bisNODAGA-16 showed a promising biodistribution profile with mainly signal in tumor (4.917 ± 0.776%ID/g, 2 h post-injection). Its rapid clearance from healthy tissues led to high tumor-to-organ ratios, resulting in highly contrasted PET images. These results were confirmed on subcutaneous xenografts of AsPC-1 tumor cells, a model of NTS1-positive human pancreatic adenocarcinoma.

References

Jan 1, 1992·Annals of the New York Academy of Sciences·P KitabgiJ N Bidard
Jan 1, 1985·Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progrès Dans Les Recherches Sur Le Cancer·J G ReeveN M Bleehen
Jan 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·D GullyA Brouard
Jul 2, 1999·International Journal of Cancer. Journal International Du Cancer·J C ReubiJ A Laissue
Oct 24, 2006·Proceedings of the National Academy of Sciences of the United States of America·Mihaela GinjJean Claude Reubi
Apr 23, 2008·Chemical Reviews·Simon M AmetameyPius August Schubiger
May 26, 2009·ACS Chemical Biology·Rebecca M MyersSteven V Ley
Jul 21, 2009·Bioconjugate Chemistry·Faisal AlshoukrAnne Gruaz-Guyon
Jun 18, 2011·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Melpomeni FaniHelmut R Maecke
Sep 3, 2011·Cancer Biotherapy & Radiopharmaceuticals·Michael GabrielIrene Virgolini
Mar 6, 2012·European Journal of Nuclear Medicine and Molecular Imaging·Melpomeni Fani, Helmut R Maecke
Mar 27, 2013·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Mai LinSuzanne E Lapi
Apr 18, 2013·Chemistry : a European Journal·Claudio BattilocchioSteven V Ley
Jun 1, 2013·Bioorganic & Medicinal Chemistry·I R BaxendaleJ W Shearman
Nov 1, 2013·Chemical Society Reviews·Eric W Price, Chris Orvig
Feb 25, 2015·Cancer Biotherapy & Radiopharmaceuticals·Ashutosh DashFurn F Russ Knapp
May 15, 2015·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Axel AndrésJosep M Huerta
Feb 13, 2016·Dalton Transactions : an International Journal of Inorganic Chemistry·Thomas W PriceGraeme J Stasiuk
Mar 5, 2016·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Jörg SchulzHolger Amthauer
Mar 18, 2016·International Journal of Oncology·Bogdan MitranAnna Orlova
Aug 25, 2016·Seminars in Nuclear Medicine·Philipp SpangFrank Roesch
Mar 4, 2017·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Jörg SchulzHolger Amthauer
Apr 15, 2017·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Jennifer D YoungPhilip J Blower
Oct 14, 2017·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Richard P BaumChristiane Smerling
Nov 9, 2017·Journal of Labelled Compounds & Radiopharmaceuticals·Simone Maschauer, Olaf Prante
Jan 9, 2018·RSC Advances·Maria Iris TsionouMichelle T Ma
May 12, 2018·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Marie BrandtThomas L Mindt
May 15, 2019·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Emma von WittingVladimir Tolmachev

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Pharmacological Research : the Official Journal of the Italian Pharmacological Society
Tao HouXinmiao Liang
Progress in Neuro-psychopharmacology & Biological Psychiatry
Bin LiKang Xi
Current Protocols in Pharmacology
P Kitabgi, Didier Pélaprat
© 2021 Meta ULC. All rights reserved